- Home
- MRKR vs TKLF Comparison
MRKR vs TKLF Comparison
Compare MRKR & TKLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRKR
- TKLF
- Stock Information
- Founded
- MRKR N/A
- TKLF 2006
- Country
- MRKR United States
- TKLF Japan
- Employees
- MRKR N/A
- TKLF N/A
- Industry
- MRKR Biotechnology: Pharmaceutical Preparations
- TKLF Other Specialty Stores
- Sector
- MRKR Health Care
- TKLF Consumer Discretionary
- Exchange
- MRKR Nasdaq
- TKLF Nasdaq
- Market Cap
- MRKR 13.4M
- TKLF 13.3M
- IPO Year
- MRKR N/A
- TKLF 2022
- Fundamental
- Price
- MRKR $1.77
- TKLF $3.79
- Analyst Decision
- MRKR Strong Buy
- TKLF
- Analyst Count
- MRKR 3
- TKLF 0
- Target Price
- MRKR $13.17
- TKLF N/A
- AVG Volume (30 Days)
- MRKR 185.7K
- TKLF 31.3K
- Earning Date
- MRKR 05-15-2025
- TKLF 07-15-2025
- Dividend Yield
- MRKR N/A
- TKLF N/A
- EPS Growth
- MRKR N/A
- TKLF N/A
- EPS
- MRKR N/A
- TKLF 1.70
- Revenue
- MRKR $5,696,123.00
- TKLF $219,520,631.00
- Revenue This Year
- MRKR N/A
- TKLF N/A
- Revenue Next Year
- MRKR $11.28
- TKLF N/A
- P/E Ratio
- MRKR N/A
- TKLF $2.24
- Revenue Growth
- MRKR 71.53
- TKLF 32.02
- 52 Week Low
- MRKR $0.95
- TKLF $2.05
- 52 Week High
- MRKR $5.99
- TKLF $8.53
- Technical
- Relative Strength Index (RSI)
- MRKR 72.77
- TKLF 51.77
- Support Level
- MRKR $1.12
- TKLF $3.57
- Resistance Level
- MRKR $1.82
- TKLF $4.00
- Average True Range (ATR)
- MRKR 0.17
- TKLF 0.22
- MACD
- MRKR 0.06
- TKLF -0.03
- Stochastic Oscillator
- MRKR 93.33
- TKLF 53.97
About MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.
About TKLF Yoshitsu Co. Ltd
Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores; Online Stores and Services; and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from China followed by Japan and other overseas markets.